IMODIUM A-D EZ CHEWS Drug Patent Profile
✉ Email this page to a colleague
When do Imodium A-d Ez Chews patents expire, and what generic alternatives are available?
Imodium A-d Ez Chews is a drug marketed by J And J Consumer Inc and is included in one NDA.
The generic ingredient in IMODIUM A-D EZ CHEWS is loperamide hydrochloride. There are eleven drug master file entries for this compound. One hundred and four suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Imodium A-d Ez Chews
A generic version of IMODIUM A-D EZ CHEWS was approved as loperamide hydrochloride by MYLAN on September 18th, 1991.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IMODIUM A-D EZ CHEWS?
- What are the global sales for IMODIUM A-D EZ CHEWS?
- What is Average Wholesale Price for IMODIUM A-D EZ CHEWS?
Summary for IMODIUM A-D EZ CHEWS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Clinical Trials: | 25 |
| Patent Applications: | 4,232 |
| DailyMed Link: | IMODIUM A-D EZ CHEWS at DailyMed |
Recent Clinical Trials for IMODIUM A-D EZ CHEWS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| MedSIR | Phase 2 |
| Gilead Sciences | Phase 2 |
| Naia Pharmaceuticals | Phase 1/Phase 2 |
US Patents and Regulatory Information for IMODIUM A-D EZ CHEWS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM A-D EZ CHEWS | loperamide hydrochloride | TABLET, CHEWABLE;ORAL | 020448-001 | Jul 24, 1997 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IMODIUM A-D EZ CHEWS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM A-D EZ CHEWS | loperamide hydrochloride | TABLET, CHEWABLE;ORAL | 020448-001 | Jul 24, 1997 | 5,489,436 | ⤷ Start Trial |
| J And J Consumer Inc | IMODIUM A-D EZ CHEWS | loperamide hydrochloride | TABLET, CHEWABLE;ORAL | 020448-001 | Jul 24, 1997 | 6,814,978 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IMODIUM A-D EZ CHEWS
See the table below for patents covering IMODIUM A-D EZ CHEWS around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 2068402 | ENROBAGE POUR MASQUER LE GOUT POUVANT ETRE UTILISE DANS DES COMPRIMES PHARMACEUTIQUES CROQUABLES (TASTE MASK COATINGS FOR PREPARATION OF CHEWABLE PHARMACEUTICAL TABLETS) | ⤷ Start Trial |
| Germany | 69210124 | ⤷ Start Trial | |
| European Patent Office | 0523847 | Enrobage masquant le mauvais goût pour la préparation de comprimés à mâcher pharmaceutiques (Taste mask coating for preparation of chewable pharmaceutical tablets) | ⤷ Start Trial |
| Spain | 2089403 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IMODIUM A-D EZ CHEWS
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0428296 | SPC/GB98/013 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch